Isolated peptides derived from mage tumor rejection antigen precursors which complex with HLA-A2 molecules
US6682731B1 · kind B1 · utility
2Cited by
3References
2Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 23, 2000 |
| Grant date | Jan 27, 2004 |
| Priority date | — |
| Expiry date | Mar 23, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K39/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Complexes of SEQ ID NO: 12 and HLA-A2 can be used to generate CTLs. They can be supplemented with IL-6 and IL-12.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.